Active Biotech in brief

Active Biotech is a company with focus on research and development of pharmaceutical products within medical areas where the immune defense is of significant importance. The research portfolio essentially contains projects for development of pharmaceuticals for neurodegenerative/inflammatory diseases and cancer. Active Biotech operations are currently focused on the laquinimod projects:

The laquinimod projects are focused on the treatment of inflammatory/neurodegenerative diseases. The diseases in which clinical development is ongoing are RRMS, PPMS and Huntington’s disease. The project has undergone, and is currently undergoing, a highly comprehensive clinical development program.

In addition, Active Biotech is pursuing a pre-clinical project, ISI. This project has, based on pre-clinical studies, potential treatment applications in both degenerative diseases and cancer.